← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 15, 2020Last known activity
Jan 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (1 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT05720715Lead sponsorPhase 4Jan 1, 2022
- NCT05720715Reponsible party - principal investigatorPhase 4Jan 1, 2022
- NCT05720715Study chairPhase 4Jan 1, 2022
- NCT05771012Lead sponsorN/AJan 1, 2021
- NCT05771012Overall official - principal investigatorN/AJan 1, 2021
- NCT05771012Reponsible party - principal investigatorN/AJan 1, 2021
- NCT04637633Reponsible party - principal investigatorPhase 2/Phase 3Aug 15, 2020
- NCT04637633Lead sponsorPhase 2/Phase 3Aug 15, 2020
Details
- Last known activity
- Jan 1, 2022